Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation

被引：10
|
作者：
Mohty, Mohamad [1 ]
Malard, Florent
机构：
[1] Hop St Antoine, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 36期
关键词：
MATCHED UNRELATED DONORS; ANTI-THYMOCYTE GLOBULIN; OPEN-LABEL; HEMATOLOGICAL MALIGNANCIES; PHASE-3; TRIAL; MULTICENTER; MARROW; PREVENTION; MORTALITY; OUTCOMES;
D O I：
10.1200/JCO.2017.76.0512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3993 / +
页数：4
相关论文
共 50 条
  • [31] Venous Thromboembolism Is Associated with Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Kekre, Natasha
    Kim, Haesook T.
    Ho, Vincent T.
    Cutler, Corey S.
    Armand, Philippe
    Nikiforow, Sarah
    Alyea, Edwin P.
    Soiffer, Robert J.
    Antin, Joseph H.
    Connors, Jean M.
    Koreth, John
    BLOOD, 2015, 126 (23)
  • [32] Ocular Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
    Westeneng, Arnaud C.
    Hettinga, Ymkje
    Lokhorst, Henk
    Verdonck, Leo
    van Dorp, Suzanne
    Rothova, Aniki
    CORNEA, 2010, 29 (07) : 758 - 763
  • [33] Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation
    Chhabra, Saurabh
    Visotcky, Alexis
    Pasquini, Marcelo C.
    Zhu, Fenlu
    Tang, Xiaoying
    Zhang, Mei-Jie
    Thompson, Robert
    Abedin, Sameem
    D'Souza, Anita
    Dhakal, Binod
    Drobyski, William R.
    Fenske, Timothy S.
    Jerkins, James H.
    Rizzo, J. Douglas
    Runaas, Lyndsey
    Saber, Wael
    Shah, Nirav N.
    Shaw, Bronwen E.
    Horowitz, Mary M.
    Hari, Parameswaran N.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (10) : 1876 - 1885
  • [34] Graft-versus-host disease after nonmyeloablative hematopoietic stem cell transplantation
    Na, II
    Shn, H
    Song, EK
    Lee, KW
    Yoon, SS
    Lee, JS
    Park, S
    Kim, BK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 43 - 43
  • [35] Gender and Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation
    Gratwohl, Alois
    de Elvira, Carmen Ruiz
    Gratwohl, Michael
    Greinix, Hildegard T.
    Duarte, Rafael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (06) : 1145 - +
  • [36] Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
    van Lier, Yannouck F.
    Vos, Jael
    Blom, Bianca
    Hazenberg, Mette D.
    GUT MICROBES, 2023, 15 (01)
  • [37] Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease
    Greco, Raffaella
    Barbanti, Maria Chiara
    Forcina, Alessandra
    Stanghellini, Maria Teresa Lupo
    Giglio, Fabio
    Morelli, Mara
    Vago, Luca
    Piemontese, Simona
    Messina, Carlo
    Sala, Elisa
    Pavesi, Francesca
    Marktel, Sarah
    Carrabba, Matteo G.
    Assanelli, Andrea
    Bernardi, Massimo
    Peccatori, Jacopo
    Corti, Consuelo
    Ciceri, Fabio
    BLOOD, 2015, 126 (23)
  • [38] Epstein-Barr Virus and B Cells in the Pathogenesis of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation
    Rezvani, Katayoun
    Champlin, Richard E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2201 - +
  • [39] The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
    Ho, VT
    Soiffer, RJ
    BLOOD, 2001, 98 (12) : 3192 - 3204
  • [40] Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Bornhäuser, M
    Schuler, U
    Pörksen, G
    Naumann, R
    Geissler, G
    Thiede, C
    Schwerdtfeger, R
    Ehninger, G
    Thiede, HM
    TRANSPLANTATION, 1999, 67 (04) : 499 - 504
12345